164 related articles for article (PubMed ID: 26526581)
21. Cathepsin L suppression increases the radiosensitivity of human glioma U251 cells via G2/M cell cycle arrest and DNA damage.
Zhang QQ; Wang WJ; Li J; Yang N; Chen G; Wang Z; Liang ZQ
Acta Pharmacol Sin; 2015 Sep; 36(9):1113-25. PubMed ID: 26095040
[TBL] [Abstract][Full Text] [Related]
22. Glycoprotein glycosylation and cancer progression.
Dennis JW; Granovsky M; Warren CE
Biochim Biophys Acta; 1999 Dec; 1473(1):21-34. PubMed ID: 10580127
[TBL] [Abstract][Full Text] [Related]
23. Overexpression of N-acetylglucosaminyltransferases III and V in human melanoma cells. Implications for MCAM N-glycosylation.
Bubka M; Link-Lenczowski P; Janik M; Pocheć E; Lityńska A
Biochimie; 2014 Aug; 103():37-49. PubMed ID: 24726881
[TBL] [Abstract][Full Text] [Related]
24. The glycomic effect of N-acetylglucosaminyltransferase III overexpression in metastatic melanoma cells. GnT-III modifies highly branched N-glycans.
Link-Lenczowski P; Bubka M; Balog CIA; Koeleman CAM; Butters TD; Wuhrer M; Lityńska A
Glycoconj J; 2018 Apr; 35(2):217-231. PubMed ID: 29502191
[TBL] [Abstract][Full Text] [Related]
25. Upregulation of N-acetylglucosaminyltransferase-V by heparin-binding EGF-like growth factor induces keratinocyte proliferation and epidermal hyperplasia.
Kimura A; Terao M; Kato A; Hanafusa T; Murota H; Katayama I; Miyoshi E
Exp Dermatol; 2012 Jul; 21(7):515-9. PubMed ID: 22716246
[TBL] [Abstract][Full Text] [Related]
26. hsa-miR-212 modulates the radiosensitivity of glioma cells by targeting BRCA1.
He X; Fan S
Oncol Rep; 2018 Mar; 39(3):977-984. PubMed ID: 29286157
[TBL] [Abstract][Full Text] [Related]
27. The biosynthesis of highly branched N-glycans: studies on the sequential pathway and functional role of N-acetylglucosaminyltransferases I, II, III, IV, V and VI.
Brockhausen I; Narasimhan S; Schachter H
Biochimie; 1988 Nov; 70(11):1521-33. PubMed ID: 2977290
[TBL] [Abstract][Full Text] [Related]
28. N-acetylglucosaminyltransferase V and beta1-6 branching N-linked oligosaccharides are associated with good prognosis of patients with bladder cancer.
Ishimura H; Takahashi T; Nakagawa H; Nishimura S; Arai Y; Horikawa Y; Habuchi T; Miyoshi E; Kyan A; Hagisawa S; Ohyama C
Clin Cancer Res; 2006 Apr; 12(8):2506-11. PubMed ID: 16638859
[TBL] [Abstract][Full Text] [Related]
29. Coexpression of beta1,6-N-acetylglucosaminyltransferase V glycoprotein substrates defines aggressive breast cancers with poor outcome.
Siddiqui SF; Pawelek J; Handerson T; Lin CY; Dickson RB; Rimm DL; Camp RL
Cancer Epidemiol Biomarkers Prev; 2005 Nov; 14(11 Pt 1):2517-23. PubMed ID: 16284372
[TBL] [Abstract][Full Text] [Related]
30. Enhanced radiosensitivity of malignant glioma cells after adenoviral p53 transduction.
Broaddus WC; Liu Y; Steele LL; Gillies GT; Lin PS; Loudon WG; Valerie K; Schmidt-Ullrich RK; Fillmore HL
J Neurosurg; 1999 Dec; 91(6):997-1004. PubMed ID: 10584846
[TBL] [Abstract][Full Text] [Related]
31. Transfection of 2,6 and 2,3-sialyltransferase genes and GlcNAc-transferase genes into human glioma cell line U-373 MG affects glycoconjugate expression and enhances cell death.
Dawson G; Moskal JR; Dawson SA
J Neurochem; 2004 Jun; 89(6):1436-44. PubMed ID: 15189346
[TBL] [Abstract][Full Text] [Related]
32. Expression of integrins α3β1 and α5β1 and GlcNAc β1,6 glycan branching influences metastatic melanoma cell migration on fibronectin.
Pocheć E; Janik M; Hoja-Łukowicz D; Link-Lenczowski P; Przybyło M; Lityńska A
Eur J Cell Biol; 2013 Dec; 92(12):355-62. PubMed ID: 24290991
[TBL] [Abstract][Full Text] [Related]
33. Down-regulation of beta1,4GalT V at protein level contributes to arsenic trioxide-induced glioma cell apoptosis.
Wei Y; Liu D; Ge Y; Zhou F; Xu J; Chen H; Yun X; Gu J; Jiang J
Cancer Lett; 2008 Aug; 267(1):96-105. PubMed ID: 18439752
[TBL] [Abstract][Full Text] [Related]
34. Efficient introduction of a bisecting GlcNAc residue in tobacco N-glycans by expression of the gene encoding human N-acetylglucosaminyltransferase III.
Rouwendal GJ; Wuhrer M; Florack DE; Koeleman CA; Deelder AM; Bakker H; Stoopen GM; van Die I; Helsper JP; Hokke CH; Bosch D
Glycobiology; 2007 Mar; 17(3):334-44. PubMed ID: 17179169
[TBL] [Abstract][Full Text] [Related]
35. Control of glycoprotein synthesis. The use of oligosaccharide substrates and HPLC to study the sequential pathway for N-acetylglucosaminyltransferases I, II, III, IV, V, and VI in the biosynthesis of highly branched N-glycans by hen oviduct membranes.
Brockhausen I; Carver JP; Schachter H
Biochem Cell Biol; 1988 Oct; 66(10):1134-51. PubMed ID: 2975180
[TBL] [Abstract][Full Text] [Related]
36. Sialylated β1, 6 branched N-glycans modulate the adhesion, invasion and metastasis of hepatocarcinoma cells.
Yu X; Zhao Y; Wang L; Chen X; Su Z; Zhang H; Yuan Q; Wang S
Biomed Pharmacother; 2016 Dec; 84():1654-1661. PubMed ID: 27847205
[TBL] [Abstract][Full Text] [Related]
37. Elevated expression of UDP-N-acetylglucosamine: alphamannoside beta1,6 N-acetylglucosaminyltransferase is an early event in hepatocarcinogenesis.
Ito Y; Miyoshi E; Sakon M; Takeda T; Noda K; Tsujimoto M; Ito S; Honda H; Takemura F; Wakasa K; Monden M; Matsuura N; Taniguchi N
Int J Cancer; 2001 Mar; 91(5):631-7. PubMed ID: 11267972
[TBL] [Abstract][Full Text] [Related]
38. A novel beta1,3-N-acetylglucosaminyltransferase (beta3Gn-T8), which synthesizes poly-N-acetyllactosamine, is dramatically upregulated in colon cancer.
Ishida H; Togayachi A; Sakai T; Iwai T; Hiruma T; Sato T; Okubo R; Inaba N; Kudo T; Gotoh M; Shoda J; Tanaka N; Narimatsu H
FEBS Lett; 2005 Jan; 579(1):71-8. PubMed ID: 15620693
[TBL] [Abstract][Full Text] [Related]
39. Elevated expression of N-acetylglucosaminyltransferase V in first trimester human placenta.
Tomiie M; Isaka S; Miyoshi E; Taniguchi N; Kimura T; Ogita K; Tsutsui T; Shimoya K; Nakagawa T; Kondo A; Koyama M; Murata Y
Biochem Biophys Res Commun; 2005 May; 330(3):999-1004. PubMed ID: 15809094
[TBL] [Abstract][Full Text] [Related]
40. Carcinoma-associated expression of core 2 beta-1,6-N-acetylglucosaminyltransferase gene in human colorectal cancer: role of O-glycans in tumor progression.
Shimodaira K; Nakayama J; Nakamura N; Hasebe O; Katsuyama T; Fukuda M
Cancer Res; 1997 Dec; 57(23):5201-6. PubMed ID: 9393734
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
